PSMA Avidity in the Heterotropic Ossification - An Incidental Finding on PSMA PET/CT

Tarun Kumar Jain; Mansha Vohra; Bhawani Shankar Sharma; Shikha Dhal; Lalit Mohan Sharma

doi:10.1097/RLU.0000000000005054

PSMA Avidity in the Heterotropic Ossification - An Incidental Finding on PSMA PET/CT

Tarun Kumar Jain
, Mansha Vohra
, Bhawani Shankar Sharma
, Shikha Dhal
, Lalit Mohan Sharma

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The upregulations of prostate-specific membrane antigen (PSMA) antigen are used for the presence of prostate cancer. However, published literature shows incidentally detected PSMA uptake in various nonprostatic benign and malignant conditions, which led to questioning the specificity of PSMA-targeted PET. In present case, we highlighted the abnormal PSMA expression in the benign bone abnormality.

Original language	English
Pages (from-to)	E118-E119
Journal	Clinical Nuclear Medicine
Volume	49
Issue number	3
DOIs	https://doi.org/10.1097/RLU.0000000000005054
State	Published - 1 Mar 2024
Externally published	Yes

Keywords

PSMA PET/CT
heterotopic ossification
prostate-specific membrane antigen

Access to Document

10.1097/RLU.0000000000005054

Cite this

@article{cdb6744a3fe44e20b84efe057b517937,

title = "PSMA Avidity in the Heterotropic Ossification - An Incidental Finding on PSMA PET/CT",

abstract = "The upregulations of prostate-specific membrane antigen (PSMA) antigen are used for the presence of prostate cancer. However, published literature shows incidentally detected PSMA uptake in various nonprostatic benign and malignant conditions, which led to questioning the specificity of PSMA-targeted PET. In present case, we highlighted the abnormal PSMA expression in the benign bone abnormality.",

keywords = "PSMA PET/CT, heterotopic ossification, prostate-specific membrane antigen",

author = "Jain, \{Tarun Kumar\} and Mansha Vohra and Sharma, \{Bhawani Shankar\} and Shikha Dhal and Sharma, \{Lalit Mohan\}",

year = "2024",

month = mar,

day = "1",

doi = "10.1097/RLU.0000000000005054",

language = "English",

volume = "49",

pages = "E118--E119",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - PSMA Avidity in the Heterotropic Ossification - An Incidental Finding on PSMA PET/CT

AU - Jain, Tarun Kumar

AU - Vohra, Mansha

AU - Sharma, Bhawani Shankar

AU - Dhal, Shikha

AU - Sharma, Lalit Mohan

PY - 2024/3/1

Y1 - 2024/3/1

N2 - The upregulations of prostate-specific membrane antigen (PSMA) antigen are used for the presence of prostate cancer. However, published literature shows incidentally detected PSMA uptake in various nonprostatic benign and malignant conditions, which led to questioning the specificity of PSMA-targeted PET. In present case, we highlighted the abnormal PSMA expression in the benign bone abnormality.

AB - The upregulations of prostate-specific membrane antigen (PSMA) antigen are used for the presence of prostate cancer. However, published literature shows incidentally detected PSMA uptake in various nonprostatic benign and malignant conditions, which led to questioning the specificity of PSMA-targeted PET. In present case, we highlighted the abnormal PSMA expression in the benign bone abnormality.

KW - PSMA PET/CT

KW - heterotopic ossification

KW - prostate-specific membrane antigen

UR - https://www.scopus.com/pages/publications/85183994000

U2 - 10.1097/RLU.0000000000005054

DO - 10.1097/RLU.0000000000005054

M3 - Article

C2 - 38271263

AN - SCOPUS:85183994000

SN - 0363-9762

VL - 49

SP - E118-E119

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 3

ER -

PSMA Avidity in the Heterotropic Ossification - An Incidental Finding on PSMA PET/CT

Abstract

Keywords

Access to Document

Fingerprint

Cite this